Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07650448 · ClinicalTrials.gov registry record · NA

WATER IV PCa (AS Sub-study)

A NA study, sponsored by PROCEPT BioRobotics.

Not yet
Registry status
NA
Development phase
333
Enrollment target

NCT07650448: Clinical Trial NA study, sponsored by PROCEPT BioRobotics.

NCT07650448 is a NA study that has not yet begun recruiting, run by PROCEPT BioRobotics. The registered enrollment target is 333 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07650448, a NA study, has not yet begun recruiting, sponsored by PROCEPT BioRobotics.

NOT YET RECRUITING
Registry status
NA
Development phase
333 participants
Enrollment target

Study Summary

The WATER IV study is a multicenter, prospective, randomized clinical trial that aims to evaluate the safety and efficacy of Aquablation therapy in men with localized prostate cancer.

Interventions

  • OTHER Active Surveillance
  • DEVICE Aquablation Therapy

Trial Details

FieldValue
Enrollment Target 333 participants
Start Date 2026-09
Est. Completion 2038-12
Phase NA
PROCEPT BioRobotics

6 total trials

What is known before NCT07650448 opens enrollment

NCT07650448 is an interventional study that assigns participants to a tested intervention. The registered 333 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower).

The record links to 0 conditions, and to 2 interventions - of which Active Surveillance is the first listed.

NCT07650448 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07650448 about?

NCT07650448 is a clinical study titled "WATER IV PCa (AS Sub-study)". The WATER IV study is a multicenter, prospective, randomized clinical trial that aims to evaluate the safety and efficacy of Aquablation therapy in men with localized prostate cancer.

What is the current status of trial NCT07650448?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 333 participants. The study started on 2026-09. Estimated completion is 2038-12.

What interventions are being tested in trial NCT07650448?

The interventions under investigation include: Active Surveillance (OTHER), Aquablation Therapy (DEVICE).

Who is sponsoring clinical trial NCT07650448?

This trial is sponsored by PROCEPT BioRobotics, which has 6 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07650448's enrollment target sits among peer trials

333 306th of 2000 higher than 1,695 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT07395687 · 333 participants · Phase 2

    A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity

  • NCT05131672 · 334 participants · NA

    Cast or Operation for Medial Epicondyle Fracture Treatment in Children

  • NCT05131685 · 334 participants · NA

    Distal Radius Interventions for Fracture Treatment

  • NCT05546931 · 334 participants · NA

    Mobile Health Program for Rural Hypertension

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT07650448, the US trial registry maintained by the National Library of Medicine. NCT07650448 (mid enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.